Patents Assigned to NEUGATE PHARMA, LLC
  • Compositions and formulations for treatment of malignancies
    Patent number: 11559500
    Abstract: The invention provides compositions, formulations, and methods for treatment of malignancies via activation of an inflammatory response in the subject. Such compositions, formulations, and methods for are preferably used in conjunction with other therapies for the treatment and/or management of malignancies, e.g., chemotherapy and/or radiation. The invention also provides methods of monitoring immune activation in subjects with malignancies.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: January 24, 2023
    Assignee: NEUGATE PHARMA, LLC
    Inventor: Yvonne Kew